Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:cancer
|
| gptkbp:affectsOrgan |
bladder
|
| gptkbp:associatedWith |
gptkb:bladder_stones
urinary tract infection |
| gptkbp:canMetastasizeTo |
lungs
liver lymph nodes bones |
| gptkbp:commonIn |
industrial workers exposed to aromatic amines
|
| gptkbp:diagnosedBy |
urinalysis
biopsy cystoscopy imaging tests |
| gptkbp:firstDescribed |
19th century
|
| gptkbp:geneticStudies |
gptkb:TP53_mutation
FGFR3 mutation |
| https://www.w3.org/2000/01/rdf-schema#label |
Bladder cancer
|
| gptkbp:ICD-10_code |
gptkb:C67
|
| gptkbp:incidence |
estimated 573,000 new cases worldwide in 2020
high in developed countries |
| gptkbp:lessCommonType |
gptkb:cancer
|
| gptkbp:mortalityRate |
high if advanced
|
| gptkbp:prevalence |
more common in men
more common in older adults |
| gptkbp:prevention |
avoid smoking
limit exposure to chemicals |
| gptkbp:prognosis |
varies by stage
|
| gptkbp:recurrence |
common
|
| gptkbp:recurrenceMonitoring |
regular cystoscopy
|
| gptkbp:riskFactor |
smoking
chronic bladder inflammation exposure to industrial chemicals family history of bladder cancer |
| gptkbp:screening |
not routine for general population
|
| gptkbp:specialty |
oncology
urology |
| gptkbp:stagingSystem |
gptkb:TNM
|
| gptkbp:symptom |
frequent urination
blood in urine painful urination |
| gptkbp:treatment |
gptkb:BCG_vaccine_(as_immunotherapy)
surgery radiation therapy chemotherapy immunotherapy intravesical therapy |
| gptkbp:type |
gptkb:urothelial_carcinoma
|
| gptkbp:victim |
estimated 212,000 deaths worldwide in 2020
|
| gptkbp:bfsParent |
gptkb:UniProt:P01112
|
| gptkbp:bfsLayer |
5
|